FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
A method for semi-automated image analysis of HLA class I tumour epithelium expression in rectal cancer
1667PDF: 788Supplementary: 218HTML: 21 -
Antigen retrieval pre-treatment causes a different expression pattern of Cav3.2 in rat and mouse spinal dorsal horn
2106PDF: 881Supplementary: 229HTML: 38 -
Developmental expression of calretinin in the mouse cochlea
1761PDF: 590HTML: 19 -
Muc5ac mucin expression during rat skin development
2539PDF: 849HTML: 721 -
Expression of nestin, parvalbumin and otoferlin during cochlear development in the mouse: an immunofluorescence study
610PDF: 540Supplementary: 53HTML: 12 -
Reliable hexokinase 3 protein detection in human cell lines and primary tissue
1950PDF: 476Supplementary: 65Uncropped Western blots: 59HTML: 14 -
GPX4 and GPX7 over-expression in human hepatocellular carcinoma tissues
3951PDF: 1223Supplementary: 464HTML: 663 -
Expression of S100β during mouse cochlear development
1480PDF: 402Supplementary: 77HTML: 9 -
Forever particles: histochemistry in the plasticene age
1399PDF: 575HTML: 58 -
Diagnosis of sudden cardiac death due to early myocardial ischemia: An ultrastructural and immunohistochemical study
2777PDF: 1319Supplementary: 254HTML: 80 -
DPY30 promotes the growth and survival of osteosarcoma cell by regulating the PI3K/AKT signal pathway
1317PDF: 658Supplementary: 109HTML: 35 -
Overexpression of MYBL2 predicts poor prognosis and promotes oncogenesis in endometrial carcinoma
2109PDF: 883Supplementary: 196HTML: 30 -
LncRNA FBXO18-AS promotes gastric cancer progression by TGF-β1/Smad signaling
1257PDF: 742Supplementary: 99HTML: 26 -
Identification of abnormally high expression of POGZ as a new biomarker associated with a poor prognosis in osteosarcoma
2030PDF: 741Supplementary: 149HTML: 31 -
Expressions of ZNF436, β-catenin, EGFR, and CMTM5 in breast cancer and their clinical significances
2365PDF: 833Supplementary: 188HTML: 19 -
VGF AS BIOMARKER OF PRE-SYMPTOMATIC PHASE OF PARKINSON’S DISEASE Manai AL1, Modi A2, Noli B1, Choudhary SM2, Ruda-Kucerova J3, Dražanová E3,4, Khairnar A2,5, Cocco C1 | 1Department of Biomedical Sciences, University of Cagliari, Monserrato, Italy; 2International Clinical Research Center, St. Anne’s University Hospital Brno, Czech Republic; 3Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; 4Institute of Scientific Instruments of the CAS, v. v. i., Brno, Czech Republic; 5Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
333 -
Overexpression of GPER1 suppressed esophageal carcinoma growth via activating cAMP pathway
682PDF: 397Supplementary: 52Original gels: 58HTML: 17 -
P38 | THE ROLE OF SPEXIN IN COLORECTAL CANCER J. Kiezun1, J. Godlewski1, M. Kiezun2, M. Gudelska1, K. Kisielewska1, A. E. Kowalczyk1, B. E. Krazinski1 | 1Department of Anatomy and Histology, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Poland; 2Department of Animal Anatomy and Physiology, Faculty of Biology and Biotechnology, University of Warmia and Mazury in Olsztyn, Poland
204 -
SUSD2 suppresses lung adenocarcinoma tumorigenesis by inducing autophagy via inhibiting PI3K/AKT/mTOR signaling pathway
189PDF: 169Supplementary: 22HTML: 7 -
Metformin sensitises osteosarcoma to chemotherapy via the IGF-1R/miR-610/FEN1 pathway
1539PDF: 938Supplementary: 100HTML: 25
